Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT00826085
Title Phase 1/2 Study of ThermoDox With Approved Hyperthermia in Treatment of Breast Cancer Recurrence at the Chest Wall
Acronym DIGNITY
Recruitment Completed
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors Celsion
Indications
Therapies
Age Groups: adult
Covered Countries USA


No variant requirements are available.